S. Ammari

D. de Ruysscher, D. Planchard, J. Adam, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy.

C. Balleyguier, É. Chouzenoux, L. Dercle, 2019, European journal of cancer.

Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation

J. Soria, E. Lanoy, C. Robert, 2018, Clinical Cancer Research.

Mechanisms and therapeutic implications of hypermutation in gliomas

Raymond Y Huang, P. Park, R. Beroukhim, 2020, Nature.

[Pulmonary tumor thrombotic microangiopathy].

F. Vincent, S. Ammari, M. Merad, 2017, Revue des maladies respiratoires.

Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4

L. Schwartz, C. Robert, L. Dercle, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.

R. Houot, L. Schwartz, L. Dercle, 2018, European journal of cancer.

Events prediction after treatment in HPV-driven oropharyngeal carcinoma using machine learning.

F. Bidault, N. Lassau, P. Blanchard, 2022, European journal of cancer.

Patterns of disease events and causes of death in patients with HPV-positive versus HPV-negative oropharyngeal carcinoma.

P. Blanchard, P. Gorphe, O. Casiraghi, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

AI-based multi-modal integration (ScanCov scores) of clinical characteristics, lab tests and chest CTs improves COVID-19 outcome prediction of hospitalized patients

Fabien, M. Sefta, T. Clozel, 2020 .

Cancer surgery during the COVID‐19 pandemic: The experience of a comprehensive cancer center performing preoperative screening by RT‐PCR and chest CT scan

T. de Baère, C. Balleyguier, P. Gorphe, 2021, Journal of surgical oncology.

Dosimetry-driven quality measure of brain pseudo Computed Tomography generated from deep learning for MRI-only radiotherapy treatment planning.

N. Paragios, Marvin Lerousseau, M. Vakalopoulou, 2020, International journal of radiation oncology, biology, physics.

Patterns of progression in patients treated for immuno-oncology antibodies combination

J. Soria, J. Armand, E. Castañón, 2020, Cancer Immunology, Immunotherapy.

Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib

D. Planchard, B. Besse, A. Levy, 2021, Cancer management and research.

Pictorial review of dynamic contrast enhanced MRI in multiple myeloma

S. Ammari, S. Moalla, I. Koubaa, 2017 .

Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors

D. Planchard, J. Adam, C. Caramella, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

From Dose Reduction to Contrast Maximization

A. Bône, C. Balleyguier, É. Chouzenoux, 2022, Investigative radiology.

Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence

Lawrence H. Schwartz, Binsheng Zhao, Laurent Dercle, 2019, EJNMMI Research.

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.

C. Balleyguier, L. Dercle, O. Lambotte, 2018, European journal of cancer.

Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer

C. Balleyguier, N. Lassau, S. Ammari, 2022, Diagnostics.

An artificial intelligence model predicts the survival of solid tumour patients from imaging and clinical data.

G. Wainrib, C. Maussion, M. Sefta, 2022, European journal of cancer.

Disseminated bone involvement in systemic sarcoidosis mimicking bone metastases. A multimodality imaging approach.

S. Ammari, F. Lioté, F. Paycha, 2011, Joint, bone, spine : revue du rhumatisme.

Reversible posterior leukoencephalopathy syndrome induced by axitinib.

B. Escudier, A. Levy, S. Ammari, 2014, Clinical genitourinary cancer.

Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade: A Case Discussion and Review of the Literature.

S. Ammari, S. Champiat, A. Marabelle, 2020, The oncologist.

Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia

P. Mordant, R. Le Goffic, E. Deutsch, 2020, bioRxiv.

High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy.

L. Schwartz, M. Gönen, Elvire Roblin, 2022, European journal of cancer.

Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients.

T. de Baère, J. Soria, C. Robert, 2022, European journal of cancer.

Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?

E. Deutsch, R. Sun, O. Lambotte, 2017, Journal of Immunotherapy for Cancer.

CMAR_A_292730 2805..2810

D. Planchard, B. Besse, A. Levy, 2021 .

P2.07-005 Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

D. Planchard, J. Adam, J. Soria, 2017 .

Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge.

A. Luciani, A. Tenenhaus, V. Vilgrain, 2022, Diagnostic and interventional imaging.

Influence of Different Measurement Methods of Arterial Input Function on Quantitative Dynamic Contrast-Enhanced MRI Parameters in Head and Neck Cancer.

F. Bidault, C. Balleyguier, N. Lassau, 2022, Journal of magnetic resonance imaging : JMRI.

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume

P. Cournède, N. Chaput, N. Lassau, 2022, Frontiers in Oncology.

Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy

Shawn H. Sun, L. Schwartz, Binsheng Zhao, 2022, Journal for ImmunoTherapy of Cancer.

Optimization of Patient Management During the COVID-19 Pandemic: Chest CT Scan and PCR as Gatekeepers of the Radiation Therapy Workflow

E. Deutsch, R. Sun, L. Dercle, 2020, Frontiers in Oncology.

Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.

Shawn H. Sun, L. Vercellino, R. Houot, 2022, Radiology.

Prognostic factors of the synovial sarcoma of the extremities: imaging does matter

J. Blay, D. Biau, A. Feydy, 2022, European Radiology.

Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: Are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?

Lawrence Dierickx, Slimane Zerdoud, Laurent Dercle, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Breast sarcoma : sixty shades of grey…

M. Mathieu, C. Balleyguier, S. Ammari, 2017 .

Risk-based stratification in head and neck mucosal melanoma.

C. Robert, L. Dercle, F. Nguyen, 2019, Oral oncology.

Synthetic MR image generation of macrotrabecular-massive hepatocellular carcinoma using generative adversarial networks.

A. Luciani, A. Tenenhaus, V. Vilgrain, 2023, Diagnostic and interventional imaging.

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics

L. Schwartz, C. Robert, L. Dercle, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

(18)F-FDG PET and CT-scan Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-PD1 Immune Checkpoint Inhibitor

Lawrence H. Schwartz, Roch Houot, Laurent Dercle, 2018 .

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

Charles Ferté, Laurent Dercle, Samy Ammari, 2016, Clinical Cancer Research.

Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies

F. Bidault, L. Dercle, S. Ammari, 2018, European Radiology.

Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.

S. Broutin, J. Delahousse, A. Paci, 2018, European journal of cancer.

Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics

Nikos Paragios, Johan Pallud, Théo Estienne, 2020, Scientific Reports.

Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody.

Eric Deutsch, Laurent Dercle, Renaud Mazeron, 2016, European journal of cancer.

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Marie-Cécile Le Deley, Stefan Michiels, Caroline Even, 2017, Cancer discovery.

Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

B. Bot, J. Soria, S. Koscielny, 2013, Clinical Cancer Research.

Synergizing liver systemic treatments with interventional oncology: friend or foe?

T. de Baère, V. Boige, S. Ammari, 2022, The British journal of radiology.

Interventional Radiology for Local Immunotherapy in Oncology

T. de Baère, J. Soria, C. Robert, 2021, Clinical Cancer Research.

Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer.

M. Ducreux, J. Soria, V. Boige, 2020, European journal of cancer.

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

J. Soria, C. Ferté, E. Castañón, 2020, Cancer medicine.

Computed tomography evaluation after induction chemotherapy for T3 laryngeal cancer: Does response correlate with vocal cord mobility?

F. Bidault, C. Balleyguier, P. Gorphe, 2019, Oral oncology.

Investigating of the role of CT scan for cancer patients during the first wave of COVID-19 pandemic

H. Rousseau, L. Dercle, S. Ammari, 2022, Research in Diagnostic and Interventional Imaging.

Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients

G. Wainrib, J. Pesquet, E. Pronier, 2021, Nature Communications.

C. Lebbé, O. Lambotte, S. Ammari, 2022, European journal of cancer.

Development of a Machine Learning Classifier Based on Radiomic Features Extracted From Post-Contrast 3D T1-Weighted MR Images to Distinguish Glioblastoma From Solitary Brain Metastasis

E. Dezamis, P. Varlet, C. Oppenheim, 2021, Frontiers in Oncology.

Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?

C. Le Péchoux, A. Levy, S. Ammari, 2018, European Respiratory Journal.

Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal Tumors

K. Hoang-Xuan, F. Ducray, M. Sanson, 2021, Neurology.

Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases

E. Lanoy, C. Robert, S. Ammari, 2018, Melanoma research.

Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer

E. Lanoy, D. Elias, M. Bayar, 2016, Annals of Surgical Oncology.

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae

C. Haie-meder, I. Dumas, Cyrus Chargari, 2018, Oncotarget.

Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma

A. Eggermont, C. Robert, J. Scoazec, 2019, Cancer Immunology, Immunotherapy.

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence

Charles Ferté, Mathilde Bateson, Eric Deutsch, 2017, Scientific Reports.

Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors

F. Ducray, Marion Benazra, D. Leclercq, 2021, Neurology: Neuroimmunology & Neuroinflammation.

The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study.

P. Chanson, X. Mariette, J. Soria, 2020, European journal of cancer.

Intratumoral Immunotherapy: From Trial Design to Clinical Practice

T. de Baère, E. Lanoy, C. Robert, 2020, Clinical Cancer Research.

Blue Lymphangitis of the Breast after Breast Cancer: Case Report

S. Ammari, C. Mateus, J. Arfi-Rouche, 2017, The breast journal.

Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion

É. Chouzenoux, N. Lassau, S. Ammari, 2022, Cancers.

Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

C. Balleyguier, É. Chouzenoux, N. Lassau, 2021, Diagnostics.

Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort

N. Chaput, F. André, J. Soria, 2020, Nature Cancer.

Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation

A. Schernberg, A. Escande, S. Ammari, 2017, Clinical and translational radiation oncology.

Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson.

C. Cuénod, R. Thiam, L. Fournier, 2014, Diagnostic and interventional imaging.

Impact of Preprocessing and Harmonization Methods on the Removal of Scanner Effects in Brain MRI Radiomic Features

C. Balleyguier, É. Chouzenoux, N. Lassau, 2021, Cancers.

Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis

A. Cohen, L. Dercle, S. Ederhy, 2021, Frontiers in Oncology.

Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors).

J. Soria, R. Sun, L. Dercle, 2017, European journal of cancer.

Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework.

O. Tillement, C. Genestie, F. Lux, 2023, Nanomedicine : nanotechnology, biology, and medicine.

LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancer.

J. Soria, B. Besse, S. Ammari, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy.

J. Soria, M. Schlumberger, C. Robert, 2016, European journal of cancer.

Can radiation-recall predict long lasting response to immune checkpoint inhibitors?

C. Robert, B. Besse, C. Le Péchoux, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study.

F. Bidault, C. Balleyguier, É. Chouzenoux, 2021, Investigative radiology.

Intratumoral Immunotherapy: Is It Ready for Prime Time?

T. de Baère, S. Ammari, S. Champiat, 2023, Current Oncology Reports.

Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case-control study.

C. Balleyguier, C. Robert, B. Besse, 2021, European journal of cancer.

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker

P. Cournède, N. Lassau, S. Ammari, 2022, Cancers.

277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial

L. Zitvogel, T. Baère, C. Robert, 2021, Journal for ImmunoTherapy of Cancer.

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers

E. Solary, T. de Baère, S. Michiels, 2018, Oncotarget.

Radiological evaluation of response to treatment: application to metastatic renal cancers receiving anti-angiogenic treatment.

L S Fournier, A. Hernigou, C. Cuénod, 2014, Diagnostic and interventional imaging.

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs

C. Balleyguier, N. Lassau, S. Ammari, 2023, Diagnostics.

Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.

F. Bidault, D. Planchard, J. Soria, 2018, European journal of cancer.

Profile and outcome of cancer patients enrolled in contemporary phase I trials.

Y. Loriot, V. Ribrag, S. Ammari, 2023, European Journal of Cancer.

Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.

E. Dezamis, A. Schernberg, A. Patrikidou, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Imaging of Brain Metastases: Diagnosis and Monitoring

M. Smits, S. Ammari, S. Bockel, 2019, Central Nervous System Metastases.

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence

J. Soria, L. Dercle, C. Ferté, 2017, Scientific Reports.

Whole body MRI in paediatric oncology.

F. Bidault, C. Dromain, C. Caramella, 2014, Diagnostic and interventional imaging.

PH-0532: Standardization of brain MRI across machines and protocols: bridging the gap for MRI-based radiomics

N. Paragios, Marvin Lerousseau, C. Oppenheim, 2020 .

Can we trust the calculation of texture indices of CT images? A phantom study

Nathalie Lassau, Bernard Asselain, Corinne Balleyguier, 2018, Medical physics.

Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.

Shawn H. Sun, L. Vercellino, R. Houot, 2023, Radiology.

MA05.11 Safety and Efficacy of Nintedanib in Combination with Pembrolizumab in Patients with Refractory/Relapsing Malignant Pleural Mesothelioma

D. Planchard, X. Paoletti, J. Soria, 2019, Journal of Thoracic Oncology.

Contrast-Enhanced Brain MRI Synthesis With Deep Learning: Key Input Modalities and Asymptotic Performance

Émilie Chouzenoux, Alexandre Bône, Nathalie Lassau, 2021, 2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI).

MA08.09 Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

C. Lefebvre, D. Ruysscher, D. Planchard, 2018, Journal of Thoracic Oncology.

Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot

R. Sun, F. Barlesi, S. Ammari, 2021, International Journal of Radiation Oncology*Biology*Physics.

Optimizing the Management of Cancer Patients Treated With Systemic Therapies During the COVID-19 Pandemic: The New Role of PCR and CT Scan

L. Dercle, M. Arnedos, S. Ammari, 2021, Frontiers in Oncology.

Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies

F. Bidault, L. Dercle, S. Ammari, 2018, European Radiology.

Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle.

D. Planchard, V. Baracos, E. Lanoy, 2022, European journal of cancer.

Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer

D. Planchard, P. Cournède, Hugues Talbot, 2023, Journal for immunotherapy of cancer.

Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology.

D. Samuel, B. Besse, O. Lambotte, 2023, European journal of cancer.

Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.

K. Hoang-Xuan, M. Sanson, A. Idbaih, 2022, European journal of cancer.

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

N. Paragios, J. Soria, J. Scoazec, 2018, The Lancet. Oncology.

Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules

L. Schwartz, Binsheng Zhao, H. Rousseau, 2019, European Radiology.

A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI

C. Balleyguier, É. Chouzenoux, N. Lassau, 2021, Diagnostics.

18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor

R. Houot, L. Schwartz, L. Dercle, 2018, The Journal of Nuclear Medicine.

Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

B. Bot, J. Soria, S. Koscielny, 2013, Clinical Cancer Research.

Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitors.

B. Besse, O. Lambotte, S. Ammari, 2022, Respiratory medical research.

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial.

D. Botsen, S. Ammari, P. Decazes, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.